| Literature DB >> 26860110 |
Alexander R van Rosendael1,2, Lucia J Kroft3, Alexander Broersen4, Jouke Dijkstra4, Inge J van den Hoogen1, Erik W van Zwet5, Jeroen J Bax1, Michiel A de Graaf1, Arthur J Scholte6.
Abstract
BACKGROUND: Coronary-computed tomography angiography (CTA) has limited accuracy to predict myocardial ischemia. Besides luminal area stenosis, other coronary plaque morphology and composition parameters may help to assess ischemia. With the integration of coronary CTA and adenosine stress CT myocardial perfusion (CTP), reliable information regarding coronary anatomy and function can be derived in one procedure. This analysis aimed to investigate the association between coronary stenosis severity, plaque composition and morphology and the presence of ischemia measured with adenosine stress myocardial CTP. METHODS ANDEntities:
Keywords: Coronary artery disease; imaging; myocardial CT perfusion; myocardial ischemia; quantitative coronary CTA
Mesh:
Substances:
Year: 2016 PMID: 26860110 PMCID: PMC5548828 DOI: 10.1007/s12350-016-0393-7
Source DB: PubMed Journal: J Nucl Cardiol ISSN: 1071-3581 Impact factor: 5.952
Definitions of quantitative CTA-derived parameters
| Parameter | Definition |
|---|---|
| Lumen area stenosis (%) | Percentage of lumen area stenosis at level of MLA. 1 − (MLA/corresponding reference lumen area) × 100% |
| Lumen diameter stenosis (%) | Percentage diameter stenosis at the MLA |
| Mean plaque burden (%) | Sum of ((vessel wall area − lumen area)/vessel wall area) per slice/number of slices |
| Lesion length (mm) | Distance between proximal and distal ends of the plaque |
| Maximal plaque thickness (mm) | Maximal distance between vessel wall and lumen |
| Remodeling index | Vessel wall area/corresponding reference vessel wall area at the level of the MLA |
CTA, computed tomography angiography; MLA, minimal lumen area
Figure 1(A) Quantitative CTA and adenosine stress CTP of an ischemic lesion. Example of a 58-year-old female patient with a lesion in the first diagonal branch and corresponding myocardial ischemia. A Automated quantitative CTA of the artery was performed. The blue lines were set proximal and distal to the lesion. The green and red lines represent non-diseased coronary artery segments proximal and distal to the lesion. The yellow and orange lines represent the reference markers for, respectively, the lumen and vessel wall. The vertical yellow line is placed at the site of maximal stenosis percentage: 76.6%. Furthermore, mean plaque burden was 79.9%; plaque volume: 129.3 mm3; lesion length: 19.0 mm; maximal plaque thickness: 2.6 mm; dense calcium volume: 36.6 mm3. B Longitudinal lumen and vessel wall contours. C Transverse lumen and vessel wall contours at the site of maximal stenosis percentage. D 3D fusion of the coronary CTA and myocardial hypo-perfusion during adenosine stress (orange, red). A stenosis in the first diagonal branch (arrow) is depicted with corresponding myocardial ischemia. E Rest CTP study showing normal myocardial enhancement. F Adenosine stress myocardial CTP showing a small anterolateral subendocardial perfusion defect (arrow). (B) Quantitative CTA and adenosine stress CTP of a non-ischemic lesion. Same data reconstructions as shown in (A). A non-ischemic coronary lesion in the proximal LCX is depicted. Maximal stenosis percentage was: 69.1%. Mean plaque burden was: 67.2%; plaque volume: 27.1 mm3; lesion length: 3.5 mm; maximal plaque thickness: 1.8 mm; dense calcium volume: 9.4 mm3. Despite the high stenosis percentage, lesion length, maximal plaque thickness, and dense calcium volume were relatively low, resulting in normal myocardial enhancement on adenosine stress
Clinical characteristics
| Baseline characteristics (n = 84) | Values |
|---|---|
| Men | 40 (48) |
| Age (years) | 62 ± 10 |
| Calcium score | 98 (19–330) |
| Diabetes | 27 (32) |
| Hypertension* | 49 (58) |
| Hypercholesterolemia† | 37 (44) |
| Current smoking | 11 (13) |
| Positive family history‡ | 42 (50) |
| Beta-blocker | 40 (48) |
| ACE-I/ARB | 39 (46) |
| Calcium antagonist | 16 (19) |
| Statin | 38 (45) |
| Acetyl salicylic acid | 25 (30) |
Data are represented as mean ± standard deviation, median (IQR), or as number (percentage).
ACE-I, Angiotensin converting enzyme inhibitor; ARB, angiotensin receptor blocker.
* Systolic blood pressure ≥140 mm Hg, diastolic blood pressure ≥90 mm Hg, or use of antihypertensive mediation.
† Serum total cholesterol ≥230 mg·dL−1 or serum triglycerides ≥200 mg·dL−1 or treatment with lipid-lowering drugs.
‡ Presence of CAD in 1st degree family members at <55 years in men and <65 years in women.
Quantitative CTA parameters for ischemic and non-ischemic lesions
| Quantitative CTA parametersa | Ischemia (n = 31) | No ischemia (n = 115) |
|
|---|---|---|---|
| Lumen area stenosis (%) | 69.0 ± 16.8 | 49.6 ± 17.2 | <.001 |
| Lumen diameter stenosis (%) | 46.7 ± 16.8 | 30.2 ± 13.1 | <.001 |
| Mean plaque burden (%) | 59.6 ± 8.7 | 52.3 ± 9.9 | <.001 |
| Plaque volume (mm3) | 68.7 (40.2–126.0) | 44.7 (24.1–80.0) | .021 |
| Lesion length (mm) | 12.3 (4.9–14.9) | 6.5 (4.0–10.4) | .033 |
| Maximal plaque thickness (mm) | 2.3 (1.8–2.7) | 1.9 (1.5–2.4) | .021 |
| Fibrous volume (mm3) | 24.7 (14.2–43.4) | 16.9 (9.6–32.9) | .068 |
| Fibro–fatty volume (mm3) | 3.9 (1.7–8.3) | 3.6 (1.5–9.9) | .928 |
| Necrotic core volume (mm3) | 0.6 (0.1–2.1) | 0.9 (0.1–1.9) | .661 |
| Dense calcium volume (mm3) | 25.8 (7.6–39.4) | 7.8 (0.0–20.2) | .005 |
| Remodeling index | 1.0 (0.9–1.1) | 1.0 (0.9–1.1) | .820 |
CTA, Computed tomography angiography.
aResults from the most severe lesion per coronary artery.
Figure 2(A) Vessel-based analysis relating stenosis percentage to myocardial ischemia. (B) Patient-based analysis relating stenosis percentage to myocardial ischemia. (C) Extent of CAD related to myocardial ischemia. CAD, Coronary artery disease; VD, vessel with ≥50% stenosis